Halozyme Therapeutics, Inc. (NASDAQ:HALO), the $1.82 billion market capped biopharma company was a mover in the last session. Shares of the company were a source of excitement, rising 8.16 percent to $14.97. The shares managed to dance between $14.09 and $15 on the day which saw a fairly large volume of shares changing hands. Halozyme Therapeutics, Inc. (NASDAQ:HALO) recently reported fourth quarter and fiscal 2013 financial performance. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened at $15.23 in last session, and closed at $14.22, while the day range of HALO stock is $14.00-$15.33.The stock showed a negative weekly performance of -11.24%.
Achillion Pharmaceuticals (NASDAQ:ACHN) has earned a consensus recommendation of “Hold” from the thirteen brokerages that are presently covering the stock, Analyst Ratings Network reports. One equities research analyst has rated the stock with a sell rating and twelve have issued a hold rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $5.29. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock opened at $3.63 in last session and closed at $3.43, by loosed -5.51%. The 52 week range was $2.26-$9.41.Company’s market capitalization is $331.60 million.
Renren Inc. (NYSE: RENN), is a leading real-name social networking internet platform in China. In view of the unusual market activity in the Company’s American Depositary Shares (ADS) on Wednesday, March 5, 2014, the New York Stock Exchange has contacted the Company in accordance with its usual practice. The Company stated that its policy is not to comment on market rumors or otherwise speculate on unusual market activity. Renren Inc (NYSE:RENN) stock loosed -6.49% and finished the last session at $4.47. The EPS of the stock remained -0.16. Company’s market capitalization is $1.66 billion.
Summer Street analyst Caraol Werther maintained a Buy rating and $10 price target on Avanir Pharmaceuticals (NASDAQ: AVNR) after meetings with management yesterday. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock opened the session at $4.99, and closed the session at $4.45. The 52 week range of the AVNR stock remained $2.60-$6.00 and the day range was $4.44-$5.00.
Leave a Reply